The NGAL Test™ As An Aid in the Risk Assessment for AKI Stage II and III in an Intensive Care Population
Clinical trial NCT03057457 · UNKNOWN
Trial details
- NCT number
- NCT03057457
- Sponsor
- BioPorto Diagnostics
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-03-01
- Primary completion
- 2017-12-01
- Enrollment
- 530
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.